Immunoscintigraphy of xenotransplanted hepatoblastoma with iodine 131- labeled anti-α-fetoprotein monoclonal antibody

Journal of Pediatric Surgery

Volumn 34, Issue 9, 1999, Pages 1378-1384

  Fuchs, Jörg ^a   Gratz, Klaus Friedrich ^b   Habild, Götz ^b   Gielow, Peter ^b   Von Schweinitz, Dietrich ^b   Baum, Richard P ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Hepatoblastoma; Radioimmunodetection; Radiolabeled monoclonal antibody; Xenografts; fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CANCER RECURRENCE; CANCER TRANSPLANTATION; CONTROLLED STUDY; DEIODINATION; DIAGNOSTIC IMAGING; HEPATOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOSCINTIGRAPHY; IODINE 131 UPTAKE TEST; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS;

EID: 13044281567     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(99)90015-5     Document Type: Article

References (38)

1. Ishak K, Glunz P: Hepatoblastoma and hepatocarcinoma in infancy and childhood. Cancer 20:396-422, 1967
2. v. Schweinitz D, Byrd D, Hecker H, et al: Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Eur J Cancer 33:1243-1249, 1997
3. Douglass E, Reynolds M, Finegold M, et al: Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: A Pediatric Oncology Group Study. J Clin Oncol 11:96-99, 1993
4. Stringer M, Hennayke S, Howard E, et al: Improved outcome for children with hepatoblastoma. Br J Surg 82:386-391, 1995
5. Reynolds M: Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study. World J Surg 19:814-816, 1995
6. v. Schweinitz D, Fuchs J, Mildenberger H: Die chirurgische Strategie bei kindlichen Lebertumoren. Langenbecks Arch Chir Suppl II: 1091-1094, 1996
7. Reynolds M, Douglass E, Finegold M: Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 27:1080-1084, 1992
8. v. Schweinitz D, Hecker H, Schmidt von Arndt G, et al: Prognostic factors and staging system in childhood hepatoblastoma. Int J Cancer 74:593-599, 1997
9. Ortega J, Krailo M, Haas J, et al: Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: A report from the Childrens Cancer Study Group. J Clin Oncol 9:2167-2176, 1991
10. v. Schweinitz D, Hecker H, Harms D: Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma. J Pediatr Surg 30:845-852, 1995
11. Klingebiel T, Bader P, Bares R, et al: Treatment of neuroblastoma stage 4 with 131 I-meta.iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study. Eur J Cancer 34:1398-1402, 1998
12. Popper H, Schaffner F: Primary hepatic tumors in children, in Ishak K (ed): Progress in liver disease. New York, NY, Grune & Stratton, 1976, pp 636-638
13. Murthy A, Vawter G, Kopido L: Biochemical studies on liver tumors in children. Arch Pathol 96:48-52, 1973
14. v. Schweinitz D, Bürger D, Bode U, et al: Ergebnisse der Studie HB-89 bei der Behandlung maligner epithelialer Lebertumoren des Kindesalter und Konzept eines neuen Protokolls HB 94. Klin Pädiatr 206:282-288,1994
15. Mildenberger H, Bürger D, Weinel P: Das Hepatoblastom: Eine katamnestische Untersuchung und Vorschlag eines Therapiekonzeptes. Z Kinderchir 44:78-82, 1989
16. Fuchs J, Schmidt D, Pietsch T, et al: Successful transplantation of human hepatoblastoma into immunodeficient mice. J Pediatr Surg 31:1241-1249, 1996
17. Snyder W, Ford M, Warner G, et al: Estimates of specific absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of heterogeneous phantoms. Pamphlet 5. New York, NY, The Society of Nuclear Medicine, 1978
18. Kalbfleisch J, Prentice R: The statistical analysis of failure time data. New York, NY, John Wiley and Sons, 1980
19. Evans A, Land V, Newton W: Combination chemotherapy (vincristine, adriamycine, cyclophosphamid, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 50:821-826, 1982
20. Shafford E, Pritchard J: Hepatoblastoma - A bit of a success story? Eur J Cancer 50:821-826, 1994
21. King D, Ortega J, Campbell J: The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. J Pediatr Surg 26:1074-1981, 1991
22. Dresel S, Kirsch C, Tatsch K, et al: Detection of hepatocellular carcinoma with a new alpha-fetoprotein antibody imaging kit. J Clin Oncol 15:2683-2690, 1997
23. Goldenberg D, Goldenberg H, Ford E: Imaging of primary and metastatic liver cancer with 1-131 monoclonal and polyclonal antibodies against alpha-fetoprotein. J Clin Oncol 5:1827-1835, 1987
24. Goldenberg D: Imaging and therapy of gastrointestinal cancers with radiolabeled antibodies. Am J Gastroenterol 86:1392-1403, 1991
25. Jones DH, Goldmann A, Gordon I, et al: Therapeutic application of a radiolabeled monoclonal antibody in nude mice xenograft with human neuroblastoma: tumoricidal effects and distribution studies. Int J Cancer 35:715-720, 1985
26. Senekowitsch R, Reidel G, Möllenstädt S, et al: Curative radioimmunotherapy of human mammary carcinoma xenografts with iodine-131-labeled monoclonal antibody. J Nucl Med 30:531-537, 1989
27. Wang Z, Stein R, Sharkey R, et al: Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model. Cancer Res 50:869s-872s, 1990
28. Sands H: Experimental studies of radioimmunodetection of Cancer: An overview. Cancer Res 50:809s-813s, 1990
29. Lehninger A: Biochemistry (ed 2). New York, NY, Worth Publisher, 1975
30. Jain R: Physiological barriers to delivery of monoclonal antibodies and other makromolecules in tumors. Cancer Res 50:814s-819s, 1990
31. Beatty J, Beatty B, O Conner-Tressel M, et al: Mechanism of tissue uptake and metabolism of radiolabeled antibody-role of antigen: Antibody complex formation. Cancer Res 50:840s-845s, 1990
32. Colcher D, Keenan A, Larson S, et al: Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts. Cancer Res 84:524-532, 1984
33. Wahl L, Parker C, Philpott G: Improved radioimaging and tumor localisation with monoclonal F(ab)2. J Nucl Med 24:316-325, 1983
34. Buchegger F, Haskell C, Schreier M: Radiolabeled fragments of monoclonal antibodies against carcinoembryonaic antigen for localization of human colon carcinoma grafted into mice. J Exp Med 158:413-427, 1983
35. Chen Q, Yuan S: Radioimmunodetection of human pancreatic carcinoma xenograft by Tc-99m labeled YPC3 monoclonal antibody. J Cancer Res Oncol 120:668-671, 1994
36. Humm J: Dosimetric aspects of radiolabeled antibodies for tumor therapy. J Nucl Med 27:1490-1497, 1986
37. Zalcberg J, Thomson C, Lichtenstein M, et al: Tumor immunotherapy in the mouse with the use of 1-131-labeled monoclonal antibodies. J Natl Cancer Inst 72:679-704, 1984
38. Habrand JL, Nehme D, Kalifa C, et al: Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children? Int J Radiat Oncol 23:525-531, 1992